Remsima® contains the active substance called infliximab.
Remsima® which is a monoclonal antibody that attaches to a chemical messenger in the body called tumor necrosis factor alpha (TNF-alpha), involved in causing inflammation. By blocking TNF-alpha, Remsima® improves inflammation and other disease symptoms.
1. Remsima® Summary of Product Characteristics. Available at: https://www.ema.europa.eu/en/documents/product-information/Remsima®-epar-product-information_en.pdf Accessed 4 Sep 2020.
TNF-α: tumor necrosis factor alpha
The link you have selected will take you to a third-party website. It is not under the review or control of Celltrion Healthcare and the company does not review or control the contents. The company does not endorse the content, its accuracy or any practices and standards contained in the website.
Please confirm if you wish to follow the link.